TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
KRRO

Korro Bio, Inc.

Healthcare · Biotechnology

10.00$ -15.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KRRO
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
90.7% 96.4% 99.2% 85.0% 72.7% 77.4% 77.9% 58.1% 72.6%
90.7% 94.7% 89.7% 83.2% 43.0% 50.1% 75.0% 24.6% 19.2%
90.7% 94.7% 97.4% 83.2% 70.5% 75.7% 75.0% 55.7% 66.2%
0.4% 0.4% 0.1% 0.1% 0.6% 0.0% 0.7% 0.9%
-0.1%
249.8% 199.9% 25.0% 27.3% 29.4% 234.3% 23.3% 29.1% 54.7%
11.2% 8.5% 23.6% 10.1% 6.2% 11.8% 8.8% 6.6% 10.5%
0.0% 0.1% 1.4% 4.0% 0.9% 0.6% 2.4%
5.0% 4.2% 0.5% 2.1% 1.5% 3.5% 3.3% 1.8% 1.5%
-149.8% -108.4% 75.0% 72.7% 70.6% -134.3% 76.7% 70.9% 45.3%
-151.2% -110.2% -30.9% -36.0% -97.2% -138.1% -82.6% -117.8% -338.2%
3.2% 1.4% 0.3% 0.2% 2.4% 0.3% 0.7% 3.9% 8.3%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?